• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE NC EMERGE® CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE NC EMERGE® CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number UNK854
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Thrombus (2101)
Event Date 03/31/2018
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr. : it is indicated that the device will not be returned for evaluation. If there is any further relevant information obtained, a supplemental medwatch will be filed. (b)(4).
 
Event Description
Same case as mdr id: 2134265-2018-03410. It was reported that chest pain and acute thrombosis occurred. In (b)(6) 2018, the patient presented with st-elevation myocardial infarction. Vascular access was obtained via the right femoral artery utilizing retrograde approach. The 100% stenosed, 12 mm in length target lesion was located in the proximal left anterior descending (lad) artery. A 6fr sheath was inserted and a guide wire was advanced and crossed the lesion. Following predilitation with a non-bsc balloon, a 3. 00x28mm synergy ii drug-eluting stent was deployed at 12 atmopsheres (atm) for 16 seconds. A 3. 25x15mm nc emerge balloon catheter was advanced for further dilatation at 12 atm for 17 seconds. Following dilatation, the devices were removed and hemostasis was successfully obtained. Post procedure, the patient was given effient and was resting comfortably with no acute distress noted. Following completion of the percutaneous coronary intervention (pci), the patient was transferred to the intensive care unit (icu) where they complained of chest pain. Repeat electrocardiogram (ecg) was performed which showed the exact same pattern as prior to the pci and a repeat angiogram confirmed acute stent thrombosis at the proximal segment of the stent. A 3. 5mm x 15 mm nc emerge balloon catheter was advanced and inflated the entire stent at 10 atm for 11 seconds, 12 atm for 6 seconds, 12 atm for 8 seconds, and 12 atm for 12 seconds. The stent appeared to have a good apposition and the vessel re-opened with timi-3 flow but there was haziness at the proximal stent segment. The physician deployed a 3. 5x18mm non-bsc stent at 14 atm for 14 seconds to cover the proximal segment of the synergy stent. The initial 100% stenosis was reduced resulting in 0% residual with normal timi-3 flow. No further patient complications were reported and the patient's status was good. The patient was kept on aggrastat infusion for 18 hours and was discharged on dual-antiplatelet with aspirin and effient. The patient was enrolled in cardiac rehab upon discharge.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameNC EMERGE®
Type of DeviceCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7459085
MDR Text Key106453901
Report Number2134265-2018-03555
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K141236
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation
Type of Report Initial
Report Date 04/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/25/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Model NumberUNK854
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received04/02/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 04/25/2018 Patient Sequence Number: 1
-
-